Trial Profile

A phase IIa, proof-of-concept study for examining the use of topical Cannabidiol CBD for the management of arthritis pain in the hand

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 05 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Mar 2022 Primary endpoint (Daily hand pain (average and maximum)) has been met as per Avecho Biotechnology media release.
29 Mar 2022 Status changed from recruiting to active, no longer recruiting according to an Avecho Biotechnology media release,
29 Mar 2022 According to an Avecho Biotechnology media release, this study was run by principal investigator, Dr Daniel Lewis, from Daniel Lewis Rheumatology Centre; and Co -investigator , Pr IainMcGregor from Lambert Initiative, Australias leading research group for discovery, development of safe cannabinoid therapeutics.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com